Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  

Amgen FIRST STEP Co-Pay Support

This is a copay assistance program

Provided by: Amgen, Inc.

TEL: 888-657-8371

FAX: 888-653-2972
Languages Spoken:


Program Website


Patient Assistance Applications

Amgen FIRST STEP Co-Pay Support: Contact program


Brand Name Medications Covered

  • Blincyto
  • Neupogen syringe
  • Imlygic
  • Nplate injectable; subcutaneous
  • Kyprolis injection
  • Prolia injectable; subcutaneous
  • Neulasta
  • Vectibix
  • Neulasta Onpro Kit
  • Xgeva

Generic Name

  • blinatumomab
  • panitumumab
  • carfilzomib injection
  • pegfilgrastim
  • denosumab
  • romiplostim injectable; subcutaneous
  • denosumab injectable; subcutaneous
  • talimogene laherparepvec
  • filgrastim syringe

Eligibility Requirements   

Insurance Status Must be commercially insured
Those with Part D Eligible? No
Income Not Required
Diagnosis/Medical Criteria Medically appropriate condition/diagnosis
US Residency Required? Must be citizen


Obtaining Patient/Doctor must call to register and enroll
Receiving Not applicable
Returning Not applicable
Doctor's Action Enroll in program, complete form and obtain patient consent
Applicant's Action Call to enroll
Decision Communicated Not specified
Decision Timeframe Not specified


Amount/Supply Not applicable
Sent To Card sent to doctor's office or to patient's home
Delivery Time Not specified
Refill Process Doctor/Doctor's office must contact the Program
Limit None
Re-application Card is valid for the enrolled patient's entire course of treatment

Additional Information

Health Care Providers must enroll in the program prior to processing the Amgen FIRST STEP Program Cards

The card is valid for the patient's entire course of treatment. Eligible patients may re-enroll at any time a new course of treatment is initiated.

Updated September 26, 2018